Jade Capital Advisors LLC Acquires 30,000 Shares of The Chemours Company (NYSE:CC)

Jade Capital Advisors LLC boosted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 75.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 70,000 shares of the specialty chemicals company's stock after acquiring an additional 30,000 shares during the period. Jade Capital Advisors LLC's holdings in Chemours were worth $1,422,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CC. Burney Co. grew its position in shares of Chemours by 0.3% in the 1st quarter. Burney Co. now owns 197,046 shares of the specialty chemicals company's stock worth $5,174,000 after acquiring an additional 601 shares in the last quarter. Lavaca Capital LLC boosted its position in Chemours by 2.7% during the 1st quarter. Lavaca Capital LLC now owns 24,658 shares of the specialty chemicals company's stock worth $648,000 after acquiring an additional 641 shares during the period. Blue Trust Inc. increased its stake in shares of Chemours by 166.9% in the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 731 shares during the last quarter. Arizona State Retirement System raised its position in Chemours by 2.1% during the second quarter. Arizona State Retirement System now owns 41,657 shares of the specialty chemicals company's stock valued at $940,000 after acquiring an additional 863 shares in the last quarter. Finally, State of Michigan Retirement System increased its holdings in shares of Chemours by 2.5% during the 1st quarter. State of Michigan Retirement System now owns 36,479 shares of the specialty chemicals company's stock valued at $958,000 after acquiring an additional 900 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on Chemours from $25.00 to $18.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 6th. UBS Group decreased their target price on shares of Chemours from $30.00 to $28.00 and set a "buy" rating on the stock in a research report on Tuesday, August 6th. The Goldman Sachs Group lowered their price objective on Chemours from $29.00 to $23.00 and set a "neutral" rating on the stock in a research note on Tuesday, September 3rd. BMO Capital Markets boosted their price target on Chemours from $30.00 to $32.00 and gave the company an "outperform" rating in a research note on Monday, October 7th. Finally, Royal Bank of Canada dropped their price objective on Chemours from $35.00 to $28.00 and set an "outperform" rating for the company in a research note on Friday, October 11th. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $25.38.

Chemours Stock Performance

CC traded down $0.18 during trading hours on Tuesday, hitting $18.70. The stock had a trading volume of 1,291,497 shares, compared to its average volume of 1,552,384. The company's fifty day simple moving average is $18.99 and its 200 day simple moving average is $22.77. The company has a quick ratio of 1.01, a current ratio of 1.89 and a debt-to-equity ratio of 5.45. The Chemours Company has a 1 year low of $15.10 and a 1 year high of $32.70. The stock has a market cap of $2.78 billion, a PE ratio of -8.61 and a beta of 1.74.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.19). The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.53 billion. Chemours had a net margin of 2.16% and a return on equity of 33.21%. The business's revenue was down 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.10 EPS. Equities analysts anticipate that The Chemours Company will post 1.32 earnings per share for the current year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Thursday, August 15th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 5.35%. The ex-dividend date was Thursday, August 15th. Chemours's payout ratio is -46.08%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.